Emmaus Life Scie Financials
This page shows Emmaus Life Scie (EMMA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Emmaus Life Scie has an operating margin of 1.8%, meaning the company retains $2 of operating profit per $100 of revenue. This below-average margin results in a low score of 26/100, suggesting thin profitability after operating expenses. This is up from -11.4% the prior year.
Emmaus Life Scie's revenue declined 25.2% year-over-year, from $16.7M to $12.5M. This contraction results in a growth score of 0/100.
Emmaus Life Scie's current ratio of 0.11 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 0/100, which could limit financial flexibility.
While Emmaus Life Scie generated -$11K in operating cash flow, capex of $1K consumed most of it, leaving -$12K in free cash flow. This results in a low score of 25/100, reflecting heavy capital investment rather than weak cash generation.
Emmaus Life Scie scores -20.45, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($1.1M) relative to total liabilities ($85.0M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Emmaus Life Scie passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Emmaus Life Scie generates $0.00 in operating cash flow (-$11K OCF vs -$7.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Emmaus Life Scie earns $0.0 in operating income for every $1 of interest expense ($231K vs $7.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Emmaus Life Scie generated $12.5M in revenue in fiscal year 2025. This represents a decrease of 25.2% from the prior year.
Emmaus Life Scie's EBITDA was $270K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 114.4% from the prior year.
Emmaus Life Scie reported -$7.5M in net income in fiscal year 2025. This represents a decrease of 16.1% from the prior year.
Emmaus Life Scie earned $-0.12 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 20.0% from the prior year.
Cash & Balance Sheet
Emmaus Life Scie generated -$12K in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 99.5% from the prior year.
Emmaus Life Scie held $2.1M in cash against $27.1M in long-term debt as of fiscal year 2025.
Emmaus Life Scie had 70M shares outstanding in fiscal year 2025. This represents an increase of 9.9% from the prior year.
Margins & Returns
Emmaus Life Scie's gross margin was 93.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.3 percentage points from the prior year.
Emmaus Life Scie's operating margin was 1.8% in fiscal year 2025, reflecting core business profitability. This is up 13.2 percentage points from the prior year.
Emmaus Life Scie's net profit margin was -60.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 21.4 percentage points from the prior year.
Capital Allocation
Emmaus Life Scie invested $313K in research and development in fiscal year 2025. This represents a decrease of 52.4% from the prior year.
Emmaus Life Scie invested $1K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 91.7% from the prior year.
EMMA Income Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.4M+19.9% | $2.8M+17.1% | $2.4M-26.9% | $3.3M-39.9% | $5.5M+1.9% | $5.4M+114.6% | $2.5M-64.5% | $7.1M |
| Cost of Revenue | $247K+64.7% | $150K-33.3% | $225K-27.2% | $309K-21.6% | $394K+63.5% | $241K-6.2% | $257K+34.6% | $191K |
| Gross Profit | $3.1M+17.4% | $2.7M+22.3% | $2.2M-26.9% | $3.0M-41.3% | $5.1M-1.0% | $5.1M+128.4% | $2.2M-67.3% | $6.9M |
| R&D Expenses | $50K-10.7% | $56K-68.2% | $176K+28.5% | $137K-6.2% | $146K-23.6% | $191K+4.4% | $183K+10.2% | $166K |
| SG&A Expenses | $1.7M-25.0% | $2.3M-1.4% | $2.3M+2.3% | $2.3M-18.3% | $2.8M+2.5% | $2.7M-4.8% | $2.9M-6.4% | $3.1M |
| Operating Income | $695K+287.8% | -$370K+62.2% | -$980K-75.9% | -$557K-167.8% | $821K+41.1% | $582K+121.2% | -$2.7M-302.2% | $1.4M |
| Interest Expense | $1.9M+15.1% | $1.7M+33.6% | $1.3M-1.7% | $1.3M-4.5% | $1.3M+38.5% | $966K-49.4% | $1.9M-12.3% | $2.2M |
| Income Tax | $579K+198.1% | -$590K-14850.0% | $4K-33.3% | $6K+700.0% | -$1K-103.2% | $31K+542.9% | -$7K+93.8% | -$112K |
| Net Income | -$2.1M-82.9% | -$1.1M+51.3% | -$2.3M-33.3% | -$1.7M-195.7% | $1.8M+183.7% | -$2.2M+49.8% | -$4.3M-459.6% | $1.2M |
| EPS (Diluted) | $-0.03-50.0% | $-0.02+50.0% | $-0.04 | N/A | $0.03+200.0% | $-0.03+57.1% | $-0.07 | N/A |
EMMA Balance Sheet
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.8M-11.1% | $23.3M+3.9% | $22.5M-4.8% | $23.6M-13.7% | $27.3M+5.4% | $25.9M-12.2% | $29.5M-16.0% | $35.2M |
| Current Assets | $4.8M-4.6% | $5.0M-11.3% | $5.7M-16.5% | $6.8M-26.5% | $9.2M+2.1% | $9.0M+14.9% | $7.8M-31.8% | $11.5M |
| Cash & Equivalents | $293K-66.9% | $886K-33.5% | $1.3M-4.0% | $1.4M+10.7% | $1.3M-17.7% | $1.5M-10.9% | $1.7M-32.8% | $2.5M |
| Inventory | $1.2M-7.6% | $1.3M-8.6% | $1.4M-12.1% | $1.6M+1.6% | $1.6M-1.1% | $1.6M+6.6% | $1.5M-10.8% | $1.7M |
| Accounts Receivable | $2.6M+26.5% | $2.1M+0.5% | $2.1M-21.4% | $2.6M-46.9% | $4.9M+7.4% | $4.6M+53.8% | $3.0M-45.9% | $5.5M |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $80.2M+1.5% | $79.0M-2.5% | $81.1M+1.2% | $80.1M-1.3% | $81.1M-2.2% | $83.0M-0.3% | $83.2M+0.3% | $82.9M |
| Current Liabilities | $64.2M+3.4% | $62.1M-4.4% | $64.9M+2.1% | $63.6M-0.9% | $64.1M+0.2% | $64.0M+2.6% | $62.4M+1.5% | $61.5M |
| Long-Term Debt | $29.1M-2.2% | $29.7M+2.5% | $29.0M+0.1% | $29.0M-1.1% | $29.3M-0.2% | $29.4M-0.2% | $29.4M-3.7% | $30.6M |
| Total Equity | -$59.5M-6.8% | -$55.7M+4.9% | -$58.6M-3.8% | -$56.5M-5.0% | -$53.8M+5.7% | -$57.0M-6.3% | -$53.6M-12.3% | -$47.8M |
| Retained Earnings | -$268.1M-0.8% | -$266.0M-0.4% | -$264.9M-0.9% | -$262.6M-0.7% | -$260.8M+0.7% | -$262.7M-0.8% | -$260.5M-1.7% | -$256.1M |
EMMA Cash Flow Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $409K+114.1% | -$2.9M-1142.3% | $279K-18.7% | $343K+131.8% | $148K+105.1% | -$2.9M-2183.6% | $140K-86.5% | $1.0M |
| Capital Expenditures | $0 | N/A | N/A | $6K+700.0% | -$1K-133.3% | $3K-25.0% | $4K-33.3% | $6K |
| Free Cash Flow | $409K | N/A | N/A | $337K+129.3% | $147K+105.0% | -$2.9M-2247.1% | $136K-86.8% | $1.0M |
| Investing Cash Flow | $0 | N/A | N/A | -$2K-300.0% | $1K-100.0% | $2.5M+62725.0% | -$4K+33.3% | -$6K |
| Financing Cash Flow | -$1.0M-452.8% | $284K+182.3% | -$345K-76.9% | -$195K+55.5% | -$438K-286.4% | $235K+124.6% | -$955K-19000.0% | -$5K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EMMA Financial Ratios
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 92.7%-2.0pp | 94.7%+4.0pp | 90.6%+0.0pp | 90.6%-2.2pp | 92.8%-2.7pp | 95.5%+5.8pp | 89.7%-7.6pp | 97.3% |
| Operating Margin | 20.6%+33.7pp | -13.1%+27.6pp | -40.7%-23.8pp | -16.9%-31.9pp | 15.0%+4.2pp | 10.8%+120.2pp | -109.3%-128.5pp | 19.2% |
| Net Margin | -61.5%-21.2pp | -40.3%+56.6pp | -96.8%-43.7pp | -53.1%-86.5pp | 33.4%+74.0pp | -40.6%+132.9pp | -173.5%-190.6pp | 17.1% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -10.0%-5.1pp | -4.9%+5.5pp | -10.4%-3.0pp | -7.4%-14.1pp | 6.7%+15.1pp | -8.4%+6.3pp | -14.7%-18.2pp | 3.4% |
| Current Ratio | 0.070.0 | 0.080.0 | 0.09-0.0 | 0.11-0.0 | 0.140.0 | 0.14+0.0 | 0.13-0.1 | 0.19 |
| Debt-to-Equity | -0.49+0.0 | -0.53-0.0 | -0.49+0.0 | -0.51+0.0 | -0.54-0.0 | -0.52+0.0 | -0.55+0.1 | -0.64 |
| FCF Margin | 12.1% | N/A | N/A | 10.2%+7.6pp | 2.7%+57.0pp | -54.3%-59.7pp | 5.4%-9.1pp | 14.6% |
Note: Shareholder equity is negative (-$63.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.11), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Emmaus Life Scie's annual revenue?
Emmaus Life Scie (EMMA) reported $12.5M in total revenue for fiscal year 2025. This represents a -25.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Emmaus Life Scie's revenue growing?
Emmaus Life Scie (EMMA) revenue declined by 25.2% year-over-year, from $16.7M to $12.5M in fiscal year 2025.
Is Emmaus Life Scie profitable?
No, Emmaus Life Scie (EMMA) reported a net income of -$7.5M in fiscal year 2025, with a net profit margin of -60.2%.
What is Emmaus Life Scie's EBITDA?
Emmaus Life Scie (EMMA) had EBITDA of $270K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Emmaus Life Scie have?
As of fiscal year 2025, Emmaus Life Scie (EMMA) had $2.1M in cash and equivalents against $27.1M in long-term debt.
What is Emmaus Life Scie's gross margin?
Emmaus Life Scie (EMMA) had a gross margin of 93.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Emmaus Life Scie's operating margin?
Emmaus Life Scie (EMMA) had an operating margin of 1.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Emmaus Life Scie's net profit margin?
Emmaus Life Scie (EMMA) had a net profit margin of -60.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Emmaus Life Scie's free cash flow?
Emmaus Life Scie (EMMA) generated -$12K in free cash flow during fiscal year 2025. This represents a 99.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Emmaus Life Scie's operating cash flow?
Emmaus Life Scie (EMMA) generated -$11K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Emmaus Life Scie's total assets?
Emmaus Life Scie (EMMA) had $21.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Emmaus Life Scie's capital expenditures?
Emmaus Life Scie (EMMA) invested $1K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Emmaus Life Scie spend on research and development?
Emmaus Life Scie (EMMA) invested $313K in research and development during fiscal year 2025.
What is Emmaus Life Scie's current ratio?
Emmaus Life Scie (EMMA) had a current ratio of 0.11 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Emmaus Life Scie's debt-to-equity ratio?
Emmaus Life Scie (EMMA) had a debt-to-equity ratio of -0.43 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Emmaus Life Scie's return on assets (ROA)?
Emmaus Life Scie (EMMA) had a return on assets of -34.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Emmaus Life Scie's cash runway?
Based on fiscal year 2025 data, Emmaus Life Scie (EMMA) had $2.1M in cash against an annual operating cash burn of $11K. This gives an estimated cash runway of approximately 2320 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Emmaus Life Scie's debt-to-equity ratio negative or unusual?
Emmaus Life Scie (EMMA) has negative shareholder equity of -$63.6M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Emmaus Life Scie's Altman Z-Score?
Emmaus Life Scie (EMMA) has an Altman Z-Score of -20.45, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Emmaus Life Scie's Piotroski F-Score?
Emmaus Life Scie (EMMA) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Emmaus Life Scie's earnings high quality?
Emmaus Life Scie (EMMA) has an earnings quality ratio of 0.00x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Emmaus Life Scie cover its interest payments?
Emmaus Life Scie (EMMA) has an interest coverage ratio of 0.0x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Emmaus Life Scie?
Emmaus Life Scie (EMMA) scores 13 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.